Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia

Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia

Abstract Background CD300s are a group of proteins playing vital roles in immune responses. However, much is yet to be elucidated regarding the expression patterns and clinical significances of CD300s in cancers. Methods In this study, we comprehensively investigated CD300s in a pan‐cancer manner us...

Full description

Bibliographic Details
Main Authors: Zi‐jun Xu, Ye Jin, Xin‐long Zhang, Pei‐hui Xia, Xiang‐mei Wen, Ji‐chun Ma, Jiang Lin, Jun Qian
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Cancer Medicine
Subjects:
CD300s
immune evasion
leukemia
pan‐cancer
prognosis
Online Access:https://doi.org/10.1002/cam4.4905

Similar Items

Similar Items